ANGLE (LON:AGL) Shares Up 6.2% – Still a Buy?

ANGLE plc (LON:AGL)’s stock price rose 6.2% during mid-day trading on Tuesday . The company traded as high as GBX 13.14 ($0.17) and last traded at GBX 13.02 ($0.16). Approximately 318,303 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 1,646,051 shares. The stock had previously closed at GBX 12.25 ($0.15).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 40 ($0.50) price objective on shares of ANGLE in a report on Wednesday, January 29th.

ANGLE Price Performance

The firm has a market capitalization of £43.18 million, a P/E ratio of -1.98 and a beta of 0.22. The company has a debt-to-equity ratio of 17.22, a quick ratio of 6.18 and a current ratio of 5.19. The business has a 50 day simple moving average of GBX 12.30 and a two-hundred day simple moving average of GBX 11.11.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.